XML 75 R65.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Discontinued Operations and Disposal Groups - Schedule of Statement of Operations (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 30, 2024
Apr. 01, 2023
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Loss on deconsolidation $ 60,639 $ 60,639
Non-refundable payments 10,150 10,150
Disposed of by Sale    
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Cash 1,356 1,356
Disposed of by Sale | Carti Heal    
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Selling, general and administrative expense 0 1,728
Research and development expense 0 396
Change in fair value of contingent consideration 0 1,710
Depreciation and amortization 0 4,264
Impairments of assets 0 0
Operating loss from discontinued operations 0 8,098
Interest expense, net 0 4,889
Other (income) expense 0 61,442
Other (income) expense 0 66,331
Loss before income taxes 0 (74,429)
Income tax benefit, net 0 0
Net loss from discontinued operations 0 (74,429)
Loss attributable to noncontrolling interest - discontinued operations 0 14,937
Net loss attributable to Bioventus Inc. - discontinued operations $ 0 $ (59,492)